Pharmacoeconomic analyses appear to account for differences in recommendations made regarding public payment when national bodies consider the same drugs for the same indication.
Barbara Mintzes, PhD
Advertisement
Articles by Barbara Mintzes, PhD
Advertisement
Latest Updated Articles
- Medicine Reimbursement Recommendations in Canada, Australia, and Scotland
September 15th 2008
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5